Back
NovoCure Vs. Expedia Group Industry Stock Comparison
Buy
58
NVCR
NovoCure
Last Price:
22.01
Seasonality Move:
12.1%
Sell
48
EXPE
Expedia Group
Last Price:
113.98
Seasonality Move:
8.66%
Buy
58
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $21.99. The Score for NVCR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Expedia Group (EXPE)
is a Sell
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $114.01. The Score for EXPE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCR Stock Price Chart
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $114.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2 | Buy |
| Relative Strength Index (14 RSI): | 84.57 | Buy |
| Chaikin Money Flow: | 280430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.59 - 18.21) | Buy |
| Bollinger Bands (100): | (12.84 - 16.62) | Buy |
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.51 | Sell |
| Relative Strength Index (14 RSI): | 32.68 | Sell |
| Chaikin Money Flow: | 1004127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.28 - 134.18) | Sell |
| Bollinger Bands (100): | (125.67 - 148.45) | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.02 | Buy |
| 20-day SMA: | 15.55 | Buy |
| 50-day SMA: | 14.64 | Buy |
| 200-day SMA: | 16.14 | Buy |
| 8-day EMA: | 19.48 | Buy |
| 20-day EMA: | 16.9 | Buy |
| 50-day EMA: | 15.36 | Buy |
| 200-day EMA: | 21.82 | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.87 | Buy |
| 20-day SMA: | 123.1 | Sell |
| 50-day SMA: | 129.38 | Sell |
| 200-day SMA: | 125.89 | Sell |
| 8-day EMA: | 114.63 | Sell |
| 20-day EMA: | 120.08 | Sell |
| 50-day EMA: | 127.21 | Sell |
| 200-day EMA: | 126.93 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.16 per share.
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $2.62 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.
NovoCure Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Expedia Group Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||